Providers’ lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination
Authors:
- 1 June 2013
- journal article
- research article
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 24 (6) , 433-439
Abstract
Summary Identification of perceptions about herpes zoster (HZ) disease, vaccine effectiveness and safety, and vaccine recommendations may impact immunization practices of physicians for HIV-infected patients. A survey was used to quantify knowledge of HZ as well as determine physician immunization perceptions and practices. There were 272/1700 respondents (16%). Correct answers for the incidence of varicella zoster virus (VZV) infection in adults and incidence of HZ in HIV-infected patients were recorded by 14% and 10% of providers, respectively. Providers reported poor knowledge of the incidence of disease recurrence in HIV-infected patients (41% correct), potency of HZ vaccine (47.5% correct) and mechanism of protection against reactivation of VZV (66% correct). Most (88%) agreed that HZ was a serious disease, and 73% believed that the burden of disease made vaccination important. A majority (75%) did not vaccinate HIV patients with HZ vaccine regardless of antiretroviral therapy status. Barriers to administration included safety concerns, concern that vaccine would not prevent HZ, risk of HZ dissemination, reimbursement issues and lack of Infectious Diseases Society of America (IDSA) guidelines. Only 38% of providers agreed that CDC guidelines were clear and 50% believed that clinical trials were needed prior to use of HZ vaccine in HIV-infected patients. Education about HZ is needed among HIV providers. Providers perceived vaccination as important, but data on vaccine safety and clear guidance from the CDC on this issue are lacking.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 YearsClinical Infectious Diseases, 2012
- The Immunogenicity and Safety of Live Attenuated Varicella-zoster Virus Vaccine in Human Immunodeficiency Virus-infected ChildrenThe Pediatric Infectious Disease Journal, 2011
- Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patientsJournal of the American Academy of Dermatology, 2009
- Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective studyAIDS, 2008
- National Survey of Primary Care Physicians Regarding Herpes Zoster and the Herpes Zoster VaccineThe Journal of Infectious Diseases, 2008
- Herpes zoster infection as an immune reconstitution inflammatory syndrome in HIV-seropositive subjects: a reviewOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2007
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Zoster Incidence in Human Immunodeficiency Virus–Infected Hemophiliacs and Homosexual Men, 1984–1997The Journal of Infectious Diseases, 1999
- Complications of varicella zoster virus reactivation in HIV-infected homosexual menAIDS, 1996
- Herpes Zoster in Patients with Advanced Human Immunodeficiency Virus Infection Treated with ZidovudineThe Journal of Infectious Diseases, 1993